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ABSTRACT  
 
The majority of people affected by Multiple Sclerosis (PaMS) experience severe and 
disabling fatigue. MS Fatigue is poorly understood and most existing treatments have limited 
effectiveness. However, a recent randomised controlled trial (RCT) showed that cognitive-
behaviour therapy with a clinical psychologist was effective in reducing MS fatigue severity 
and impact. The current study developed an Internet-based version of this intervention to 
make it available to a wider group of PaMS and conducted preliminary investigations of its 
efficacy, feasibility and cost-effectiveness in a pilot RCT.  
 
The ‘MS Invigor8’ website was developed using agile design and substantial input from 
PaMS.  The programme includes eight online tailored and interactive sessions along with 
homework tasks, intended to be accessed weekly.  In the pilot trial, 40 patients were 
randomised to MS Invigor8 (n=23) or standard care (n=17). The MS Invigor8 group  
accessed sessions over 8-10 weeks and received up to three 30-50 minute telephone support 
sessions. Participants completed online questionnaires assessing fatigue, mood and quality of 
life at baseline and 10 weeks follow-up.  
 
Large between group treatment effects were found for the primary outcomes of fatigue 
severity (d=1.19) and impact (d =1.22).  The MS Invigor8 group also reported significantly 
greater improvements in anxiety and depression. Analysis suggested that the intervention 
may be cost-effective.  Qualitative feedback suggested that participants considered this 
treatment approach acceptable and helpful. Technical website problems negatively affected 
some users’ experiences and need to be resolved.  Given the promising results a larger RCT 
with longer term follow-up is warranted.  
Multiple Sclerosis (MS) is a chronic, incurable neurological disease which affects more than 
2.5 million people worldwide (1).  Fatigue is reported by around 90% of people affected by 
MS (PaMS) with over two-thirds complaining it is their most troubling symptom (2). Fatigue 
is a major reason for unemployment in MS (3) and is associated with depression and inability 
to carry out day-to-day tasks (4;5).  
 
Few treatments have been shown to be effective for MS fatigue. Evidence from 
pharmacotherapy trials is inconsistent and effects are modest at best (4;6). Other studies have 
used a more behavioural approach using either exercise or energy conservation methods but 
again results are mixed (3). These interventions are limited by the absence of a clear 
conceptualisation of MS fatigue. We recently developed a cognitive-behavioural 
conceptualisation of MS fatigue integrating the findings across biological and psychosocial 
research (6). Based on this model, we developed a cognitive behavioural therapy (CBT) 
programme which was shown in a randomised controlled trial (RCT) to effectively reduce 
fatigue up to six month follow-up (7).  
 
Despite these promising results, rolling out individual CBT for MS fatigue is likely to be 
problematic. Few MS services have access to a CBT therapist and attending therapy sessions 
may be difficult for many PaMS. The provision of CBT-based self-management programmes 
over the Internet is a rapidly evolving and potentially beneficial means of delivering 
treatment otherwise unsought or unobtainable (8). There is growing evidence that Internet-
based interventions are an effective form of treatment for a variety of physical symptoms, 
including back pain, headache and tinnitus (9-11) particularly when supplemented by some 
telephone support (12). 
 
The initial aim of the current study was to develop an Internet self-management package for 
MS fatigue (MS Invigor8) based on our therapist-delivered CBT programme and formalised 
feedback from (PaMS).  The second aim was to conduct a pilot RCT of MS Invigor8. The 
aims of the pilot were to 1) assess the feasibility of conducting automated trial randomisation 
and baseline and follow-up assessment procedures online, 2) evaluate adherence to the 
treatment programme, 3) assess the potential efficacy of the programme in reducing fatigue 
severity and impact (primary outcomes), and depressed and anxious mood (secondary 
outcomes) at 10 weeks post randomisation,  4) conduct a preliminary cost-effective analysis 
of the programme, and 5) gather detailed qualitative feedback on the programme from 
participants to make revisions if necessary before we consider a full sized RCT. 
 
Method 
 
Phase 1: Developing MS Invigor8: Breaking the Cycle of Fatigue 
Agile design (13) was used to develop MS Invigor8. Agile design incorporates a co-design 
team who work closely together to produce software, whilst maintaining constant links with 
the end user. The design team included a software project manager (GW), software 
developers, health psychologists (RM, LY) and an expert paMS. The website was designed in 
a modular, iterative fashion. Six volunteers with MS fatigue (two men, four women, mean 
age 45, with different types and severity of MS, and differing computer skills) assisted the 
co-design team.  They tested the modules in their own homes as they were developed. 
Immediately after completing each module, they were interviewed on the telephone using a 
variant of the ‘think aloud’ method (14) which is used to understand the different 
perspectives of individual users. Feedback was elicited about their experience of the module, 
focusing on issues of usability, usefulness and acceptability of the information, and 
suggestions for improvements. Interviews were recorded, transcribed verbatim, and analysed. 
The feedback was used to modify session content and programme functionality. The 
programme is summarised in table 1 and described under treatment below.  
 
 
Phase 2: Pilot Study  
 
Design and trial procedures. 
The pilot RCT study was approved by the University of Southampton ethics committee. The 
website was designed to incorporate all trial and treatment procedures.  Participant 
information sheets including eligibility criteria were presented online with the facility to 
contact the investigators for more information.  PaMS who wanted to participate consented 
online and completed an online screening questionnaire to confirm eligibility.  Those who 
were eligible could then consent to enter the trial and complete the baseline questionnaire.  
They were allocated to MSInvigor8 or a control group by an automated simple randomisation 
system built into the website.  Participants were alerted to complete the online follow-up 
questionnaire at 10 weeks post randomisation.  Control participants were given access to 
MSInvigor8 once they had completed the 10 week questionnaire, but they did not receive the 
telephone support.   
 
Recruitment and eligibility 
 
Recruitment was through advertisements on the MS Society and MS Trust websites and a 
local press release. Participants were required to be UK Resident, have a definite diagnosis of 
MS from a neurologist, have significant fatigue indicated by a score >4 on the Fatigue scale 
using the binary scoring method (15), and be ambulatory with or without a stick for at least 
100 meters. Participants had to be willing to abstain from starting new treatments for fatigue 
for the study duration.  
 
The recruitment target was to randomise 40 participants within the two month recruitment 
period.  A pilot Phase II trial of at least 30 subjects is considered adequate for obtaining 
reasonably reliable sample size estimates (16). A slightly larger sample size allowed us to 
account for possible loss to follow-up to estimate sample size for a full Phase III trial as well 
as to assess trial methodologies and procedures across a range of people. 
 
112 people underwent the automated screening process. 74 of the 112 screened did not 
register for the trial.  Reasons for non-registration are outlined in Figure 1. 
 
48 of the 112 people screened registered for the trial of whom 8 had to be withdrawn. 3 
people were excluded as they were subsequently found to be non-UK resident. Five 
participants who registered and were randomised to the control group were withdrawn 
because a website bug allowed them to access sessions on MSInvigor8 during the control 
period. Twenty-three people were randomly allocated to the MSInvigor8 group and 17 to the 
control group.  Recruitment took a total of 61 days.   
 
Treatment  
The programme entitled ‘MS Invigor8: Breaking the Cycle of Fatigue’ consists of 8 weekly 
sessions summarised in table 1.  On average, sessions take between 25 to 50 minutes to 
complete. All sessions are interactive and include self-assessments which allow the 
programme to be tailored to the individual problems and progress of the PaMS.   Educational 
information can be printed.  Sessions include homework tasks which are saved online in a 
Workbook, can be printed, and are reviewed in the subsequent session.  Other features of the 
site include programme instructions, a ‘take a break’ button allowing people to rest during 
sessions, a time bar indicating progress through a session, and optional video/audio clips 
demonstrating relaxation techniques.  
 
During the trial, the MS Invigor8 group received automated emails encouraging  the 
completion of one session per week over 8-10 weeks.  Participants also received three 
telephone support sessions of between 30-50 minutes, while they worked through the 
programme. The first was scheduled after the completion of the initial session and focused on 
talking through the personal five part model (see table 1, session 1). The second took place in  
week three and focused on clarifying goal setting and progress with goals.  The final session  
in week six focused on identifying and challenging unhelpful thoughts.   Sessions were 
provided by an assistant psychologist who received 5 hours of basic training in the 
interventions and fortnightly supervision from a registered psychologist (RMM).  All sessions 
were audiotaped and fidelity to the treatment procedures was cross-checked throughout the 
trial.   
 
Assessments 
Participants provided demographic data, and information on their MS type and duration. 
Questions to quantify MS type were drawn from previous research (17). Ambulation ability 
was measured using the ambulation questions from the self-report Expanded Disability Status 
Scale (18).   
 
The primary outcomes were:  
1) Fatigue severity, measured by the ordinal version of the Fatigue Scale (15). This 
questionnaire measures physical and mental fatigue severity, was used in the CBT 
therapist trial for MS fatigue (7) and has good psychometric properties . Cronbach’s α 
in this sample was excellent (.83) 
2) Fatigue impact, assessed by Modified Fatigue Impact Scale (19), a shortened version 
of the Fatigue Impact Scale (20).  This scale taps perceived limitations in cognitive, 
physical and psychosocial functioning as a result of fatigue.  The scale has been 
validated in people with MS (20). Cronbach’s α  in this sample was excellent (.81)  
 
The secondary outcomes were anxiety and depression, measured by the Hospital Anxiety and 
Depression scale (HADS) which was specifically designed to measure mood disturbance in 
people with physical illness (21).  Cronbach’s α was .84 for anxiety and .72 for depression. 
   
For the economic evaluation, participants completed the EuroQol (EQ5D) (22) as a measure 
of quality-adjusted life years (QALYs), and service use during the 10-week follow-up period 
was measured with an adapted version of the Client Service Receipt Inventory (CSRI) (23).  
 
Fifteen of the 23 MS Invigor8 participants agreed to be interviewed about their experiences 
of the intervention. A health psychology researcher independent of the trial team conducted 
semi-structured interviews based around experiences of fatigue, treatment expectations and 
how the participant was feeling following the intervention. Participants were also asked about 
experiences of using MS Invigor8 and the telephone support and specific elements they had 
found helpful and unhelpful. Data-driven thematic analysis was used to identify common and 
salient themes (24;25).   
 
Statistical analysis 
Analyses were performed using SPSS for Windows (Version 17; SPSS Inc, Chicago, IL). As 
this is the pilot study, data were presented descriptively.  We also conducted treatment effect 
analyses by intention-to-treat; for participants that dropped out, baseline scores were carried 
forward to post-treatment.  The exception to this was the five control participants who had 
erroneously accessed MSInvigor8.  They only provided baseline data and were removed 
entirely from all analyses as they were deemed to no longer be true controls.  As they did not 
provide follow-up data, their inclusion would have seriously biased the results in favour of 
the treatment group.  Differences between groups were analysed using general linear models 
with group as the fixed factor, baseline values as covariates and post treatment scores as the 
dependent variable.   
 
Economic analysis 
Service costs were calculated by combining the service use data with appropriate unit costs 
(26). QALYs were calculated by adding the baseline and follow-up EQ-5D scores and 
dividing by 2, assuming a linear (change over time) and multiplying by 10/52 (which is the 
maximum QALY gain attainable in the follow-up period).  
 
Results 
 
Participants 
Table 2 shows characteristics of the participants.  The mean age was early forties, most 
participants were female, and 30% were unemployed or working less because of their MS.  
The groups were well matched for age and time since diagnosis.  However, the intervention 
group had a slightly lower percentage of females, a greater percentage of people with 
progressive disease, and greater levels of ambulatory difficulties than the control group.   
 
Three of the 23 treatment participants failed to complete follow-up assessments.  They were 
the lowest users of the site, with one not completing any sessions. One of the controls did not 
complete follow-up assessment but no reason was given.  
 
Adherence to intervention 
At the 10 week assessment point the mean number of sessions completed was 4.91 (SD 2.10). 
Only one (4.3%) participant finished all 8 sessions and three (13%) finished 7 sessions.  
Overall 15 (60.8%) patients finished more than half the sessions (>5) with only one (4.3%) 
patient not completing any sessions.  
 
Participants still had access to the website after the end of the assessment period and 
continued to complete sessions as captured by the automated record of sessions completed. 
The mean number of sessions completed one month post the assessment period was 6.1 (SD 
2.45) with 11 people having completed all 8 sessions (47.8%) and 19 (82.5%) having 
completed more than half the sessions.   
 
21 (91%) participants completed the initial telephone support session (mean length 52.43 
minutes, SD 15.35). 19 (82%) participants completed the second session (mean length 30.21 
minutes, SD 7.8) and 15 (65%) completed the final session (mean length 45.6 minutes, SD 
14.18).   Reasons for cancellations included work commitments or other appointments, illness, 
not having completed the MS Invigor8 session and non-response.  No adverse events were 
reported. 
 
Descriptive outcome data 
The means and standard deviations for the outcome data across groups are presented in table 
3.  The groups appear well matched on baseline levels of fatigue and mood. The control 
group appears to show little change over the 10 weeks in all four outcomes, whilst the 
treatment group shows decreases on both fatigue measures as well as anxiety and depression.    
 
Analysis of Primary outcomes 
The MS Invigor8 group showed significant reductions when compared to the control group 
on both the Fatigue Scale (F(2,37)= 15.55, p<.001) and the Modified Fatigue Impact Scale 
(F(2,37)= 14.67, p<.001).   The between group effect size for the fatigue scale was d=1.19 
[95% CI -1.28-3.98] and for the Modified Fatigue Impact Scale, d=1.22 [95% CI -0.62-2.31]. 
 
 
Analysis of Secondary outcomes 
There were significant differences between the groups on anxiety (F(2,36= 12.31, p=.001) 
and depression (F(2,36)= 13.33, p=.001), with the MS Invigor8 group showing significantly 
greater reductions on both scales. 
 
We re-ran the outcome analysis controlling for gender and ambulation status and a completer 
only analysis (those who returned follow-up), and the results retained their significance levels 
for all outcomes.  
 
Cost-effectiveness 
During the follow-up period the most commonly used services were neurologists and general 
practitioners (Table 4). Mean costs were very similar in the intervention (£211) and control 
(£214) groups. There is therefore no evidence that during the treatment period the 
intervention had any impact on the use and cost of other services. Medication costs were not 
included, although it is unlikely these would differ between groups. Two participants in the 
control group did start to receive a disease modifying agent during the follow-up period but it 
is difficult to assess whether this would be due to lack of the intervention.  
 
The mean (SD) EQ-5D scores at baseline were 0.56 (0.26) in the intervention group and 0.64 
(0.28) in the control group. By follow-up the scores were 0.71 (0.28) in the intervention 
group and 0.62 (0.27) in the control group. The mean score at follow-up, adjusted for 
baseline, was 0.15 higher for the intervention group (p=0.038). The mean (SD) QALY gain 
for the intervention group was 0.1212 and 0.1243 in the control group. However, due to the 
quality of life difference at baseline the QALY gain was 0.015 higher in the intervention 
group (p=0.038). 
 
Qualitative feedback from people in the treatment group.  
The interviews (n=15) revealed that most participants perceived an improvement in their 
fatigue, felt they understood their fatigue better, were more in control of it and were trying to 
implement lifestyle changes suggested by the programme. 
 
 “It’s like somebody offering a helping hand, and that psychologically has been a 
huge boost to me. That there is this therapy out there that can make a difference. It’s 
not going to cure my MS, but it will help me handle it.” (female, 60 years)  
 
“I wasn’t aware of how much certain things did have an impact on my fatigue, and 
how I could go around and help myself by sort of training my brain to think 
differently almost, um, or to deal with things differently,” (females, 36 years) 
 
“I don’t have any fatigue at the moment um compared to when I started I feel more 
have more higher energy levels” (male,  32 years)  
 
The telephone support was perceived as augmenting the Internet-based sessions by nearly all 
participants. 
 
 “It was actually really good to talk to her because I was able to relate what I was 
learning … in the sessions, to my personal circumstances.” (female, 35 years)  
 
“The programme on its own, without the therapy sessions, would be … 50 percent as 
effective. The talking … sessions, certainly for me, have been vital.” (female, 60 
years)  
 
The structure of the programme was generally well accepted but occasional technical 
difficulties with the programme were detrimental to many users’ experiences, especially 
those using certain Internet browsers.  Participants also offered suggestions for modifications 
to website layout and operation. Further customisation was seen as necessary by some, 
including a few people with progressive forms of MS suggesting that the programme may be 
more relevant to those with relapsing-remitting MS.  
 
 
Discussion 
 
This study developed a novel Internet based intervention, MS Invigor8, which has the 
potential to make CBT based self-management for fatigue more widely available to PaMS.  
Strengths of the programme included its iterative development process with input from PaMS 
and its basis on a  theoretical and evidenced-based approach for treating MS fatigue  (6;7).  
The pilot data suggest that MSInvigor8 has the potential to effectively reduce both severity of 
fatigue and its impact on daily living.  The between group effect sizes for the fatigue 
measures at the end of treatment were well above the 0.80 cut-off for a large treatment effect 
(27). MS Invigor8 also had a significant positive effect on both anxiety and depression.  
These data add to a growing body of literature showing that Internet-delivered self-help CBT 
with minimal therapist support is an effective treatment option for a range of symptom based 
problems such as tinnitus, headache, chronic pain, insomnia and irritable bowel syndrome 
(28;29). 
 
In terms of economics, we measured other service costs rather than direct cost of the 
intervention because the latter would depend on how many people in routine practice made 
use of it. Service costs were very similar between the groups over the 10 week period.  
However, this period may be too short to show much change in service use costs.  The 
intervention produced more QALYs. To achieve a cost per QALY of £20,000 (below which 
interventions in England are usually recommended) the intervention costs would need to be 
no more than £300 per person (£20000 divided by 0.015 QALYs), or approximately £50 per 
session. If the intervention were never used beyond the 23 in the intervention group then this 
would only cover £6900 development costs. However, if the intervention is effective it is 
likely to be used by many more. If 300 people used it then this would cover a £90,000 
development cost which is above the actual costs that were accrued. More widespread use 
would clearly offset these costs to greater extent, as would maintaining the QALY gain 
beyond 10 weeks. 
 
Internet delivery of the intervention appeared to be acceptable to most participants. PaMS 
self-referred into this study.  Recruitment targets were met quickly suggesting that PaMS are 
self motivated to receive such treatments.  There were also few drop outs.  In depth interview 
feedback was largely positive, with many participants finding MS Invigor8 more helpful than 
other treatments they had tried.  The telephone support was also seen by most as a key 
component of the treatment.  Negative feedback centered on problems with website bugs 
rather than the nature of the treatment. Additional feedback was given to improve on minor 
aspects of the intervention structure and content.  These revisions and bug fixing will 
improve the programme for future users.   
 
The adherence data suggests that patients struggled to complete the programme within ten 
weeks. Interestingly a number of people continued with the website treatment after the study 
was finished.  Thus, a longer treatment period may be required, possibly with more structured 
support by email or telephone to assist with progress.  
 
In the original therapist trial of CBT for MS fatigue, all PaMS in the CBT group completed 
the 8 sessions (7).  The average change on the Fatigue Scale in the original trial was 13.04 
points compared to 9 points in the current study.  The eligibility criteria for both trials were 
the same and the baseline fatigue scores were similar.  It would therefore be interesting to 
investigate the relative clinical and cost-effectiveness of these two approaches in a future trial.  
Further research comparing different doses of therapist time alongside the website would help 
ascertain optimal contact time.  Therapist skill may also influence treatment effects; therapy 
support in this study was provided by a psychology assistant with minimal CBT experience, 
whereas the therapy trial included an experienced clinical psychologist  
 
This study suffered certain limitations linked to the Internet technology.  The development of 
the website proved extremely time-consuming. This part of the project overran leaving 
insufficient time to adequately test the website before we went to trial. This meant that many 
participants encountered bugs in the programme. Most could work around these, but the 
qualitative data suggested that the problems negatively affected participants’ treatment 
experiences.  Problems also occurred with using the website for trial procedures such as 
screening and self-entry into the trial. It had been hoped that incorporating these into the 
website would be a feasible means of reducing trial research costs and widening the 
recruitment base. However, our experiences suggest that handling these trial procedures 
independently will provide better control over recruitment and eligibility. 
 
The current study was a small pilot/feasibility trial of volunteers recruited over the internet 
and there was no long term follow-up data.  A larger more definitive RCT is now needed with 
longer term follow up to examine maintenance of treatment gains.   
 
Conclusion 
Internet CBT based self-management appears to be a promising, acceptable and cost-effective 
approach for treating MS fatigue and improving broader outcomes such as distress. If future 
research replicates these findings MSInvigor8 may be a feasible means of delivering a CBT-
based intervention to a large pool of PaMS who experience troubling and disabling fatigue. 
  
 
Figure 1: participant flow through the trial 
 
1  
An initial website fault meant that 5 participants allocated to the waiting list control were able to 
access the web site. These people were withdrawn from the trial  
2 
Baseline data missing for one control on three of the outcome measures.  For these analyses only 
16 controls are included but the primary data is analysed for 17 
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Table 1: Outline of  MSInvigor8 sessions. 
Session Content 
1 Title: Understanding MS fatigue 
Overview of MS fatigue. Self-assessment of biological, behavioural, cognitive, emotional and 
environmental factors which may be contributing to fatigue.  Computer generated 5-part personal 
cognitive behavioural (CB) model of MS fatigue based on self-assessment data.  
2 Title: Fatigue Diary  
Introduction to self-management based on CBT principles including the role of homework. 
Interactive tasks include the steps of keeping daily diaries of activity, rest and fatigue levels. 
Homework:  Daily fatigue diary 
3 Title: Rest and Activity Patterns.  
Review of diary. Education on how erratic patterns of rest and activity or over-activity affect 
fatigue. Importance of consistency is outlined, and benefits of moderate physical exercise 
discussed. Interactive tasks include the steps of goal setting (what, when, where). 
Homework:  Set and monitor rest and activity goals and exercise goals  
4 Title: Improving Sleep 
Self-assessment of sleep patterns. Education on behavioural techniques (basic sleep hygiene) to 
improve sleep are discussed, e.g. having set ‘worry times’, getting up if lying awake in bed for 
longer than 20 minutes.   
Homework:  Set and monitor goals for improving sleep. 
5 Title: Understanding MS Symptoms 
Education on normal symptom fluctuations versus signs of relapse and disease progression. The 
effect on fatigue of symptom focusing and attributing all symptoms to MS is introduced.  
Interactive task to generate possible alterative attributions for somatic symptoms e.g. stress, 
medication side effects. 
Homework:  Recording somatic symptoms and generating alternative attributions. 
6 Title: Recording Thoughts 
The concept of unhelpful thoughts is introduced, and how these impact on fatigue and mood.  
Interactive tasks include identifying cognitive errors and generating alternate thoughts.  
Homework: Daily thought records of unhelpful thoughts and possible alternatives. 
7 Title: Managing Stress 
Basic stress management is discussed. Interactive tasks include identifying stressors which are 
controllable and those which are not, and matching these to appropriate stress management 
strategies.   
Homework:  Goals for stress management  
8 Title: Emotions, Support and the Future 
The importance of social support is discussed, and how to access better social support.  Interactive 
tasks include identifying possible sources of support for different types of support needed. 
Managing difficult emotions and relapse are  reviewed.   
Homework: Building tool set for long term fatigue management and possible relapse.   
 
 
 Table 2: Baseline demographic characteristics of MS participants in the CBT and Control 
Groups.  
 
 MS Invigor8 group 
 (n=23) 
Control group  
(n=17) 
 
Age (M,SD) 40.14 (17.76) 41.81 (11.43) 
Time since diagnosis in years (M,SD) 21 (9.05) 16 (7.88) 
Gender (n) %  female  (16) 69.6% (16) 94.1% 
Years of Education  13.95 (4.83) 11.85 (5.01) 
Marital status (n) % 
 -Single 
 -Living with partner 
- Divorced/widowed 
- Missing data 
 
 
(4) 17.4% 
(14) 60.9% 
(5) 21.7% 
__ 
 
(4) 26.7% 
(8) 53.3% 
(3) 17.6% 
(2) 11.8% 
Ambulation status (n) %   
- Able to walk 500m or more without aid 
or rest 
- Able to walk 100m without aid or rest 
- Require unilateral or bilateral aid to 
walk 20 to 100m  
- Missing data 
 
 
(9) 39.1% 
 
(4) 17.4% 
(9) 39.1% 
 
(1) 4.4% 
 
(10) 58.8% 
 
(2) 11.8% 
(4) 23.5% 
 
(1). 5.9% 
 
 MS type (n) %  
 -Relapsing remitting 
 -Secondary progressive 
 -Primary progressive 
 -Unsure 
 
 
(10) 43.5% 
(7) 30.4% 
(2) 8.7% 
(4) 17.4% 
 
(12) 70.6% 
(2) 11.8% 
- 
(3)17.6% 
Employment related to MS 
     -working less or off sick 
     -unemployed 
 
 
(2) 9.0% 
(7) 31.8% 
 
(1) 5.8% 
(4) 23.5% 
 
Note. M=mean; SD=standard deviation.  
Table 3:  Means and standard deviations for the primary and secondary outcome measures across 
groups at baseline and 10 weeks follow-up.   
Group Pre-treatment 
(baseline) 
Post treatment 
(10 weeks) 
 
Fatigue Scale, mean (SD) 
MSInvigor8 (n=23) 21.39 (4.30) 12.39 (6.84) 
Control group (n=17) 21.53 (3.62) 19.57 (5.20) 
 
Modified Fatigue Impact Scale, mean (SD) 
MSInvigor8 (n=23) 13.17 (3.81) 9.00 (3.75) 
Control group (n=17) 12.69 (3.89) 12.88 (3.89) 
 
HADS Anxiety, mean (SD) 
MSInvigor8 (n=23) 8.26 (4.31) 6.44  (3.91) 
Control group (n=16) 9.56 (4.50) 11.65 (5.26) 
 
HADS Depression, mean (SD) 
MSInvigor8 (n=23) 7.96 (3.64) 5.18 (3.38) 
Control group (n=16) 6.75 (2.72) 8.73 (3.62) 
 
 
 Table 4. Service use and costs (2007/8 £s) at follow-up. 
 
 MSInvigor8 Control 
Service N (%) 
using 
service 
Mean 
(SD) 
contacts
1 
Mean 
(SD) 
cost
2 
N (%) 
using 
service 
Mean 
(SD) 
contacts
1 
Mean 
(SD) 
cost
2 
Neurology outpatient 3 (15) 1.7 (1.2) 32 (92) 6 (38) 1.2 (0.4) 56 (81) 
Other outpatient 3 (15) 1.0 (0.0) 15 (36) 3 (19) 1.7 (1.2) 31 (79) 
Neurology day-patient 1 (5) 1.0 (-) 6 (26) 0 (0) - 0 (0) 
Residential care 0 (0) - 0 (0) 0 (0) - 0 (0) 
Urology inpatient
3 
0 (0) - 0 (0) 0 (0) - 0 (0) 
Intensive care unit
3 
0 (0) - 0 (0) 0 (0) - 0 (0) 
Other inpatient 2 (10) 1.0 (0.0) 49 (152) 1 (6) 1.0 (-) 31 (123) 
General practitioner 11 (55) 1.3 (0.5) 24 (29) 11 (69) 3.9 (8.3) 28 (25) 
Neurologist (non-outpatient) 4 (20) 1.0 (0.0) 17 (36) 6 (38) 1.0 (0.0) 23 (35) 
Other specialist 0 (0) - 0 (0) 0 (0) - 0 (0) 
Physiotherapist 3 (15) 1.7 (0.6) 7 (21) 4 (25) 2.3 (1.0) 17 (35) 
Social worker 2 (10) 4.0 (2.8) 43 (185) 0 (0) - 0 (0) 
Nurse 3 (15) 1.0 (0.0) 3 (7) 5 (31) 3.4 (3.9) 20 (56) 
Home help 1 (5) 4.0 (-) 13 (57) 0 (0) - 0 (0) 
Other 3 (15) 2.0 (1.0) 2 (7) 2 (13) 1.0 (0.0) 2 (4) 
 
Total 
   
211 (299) 
   
214 (239) 
 
1
 Contacts are for those using services only, 
2
 Costs are for all participants, 
3
 Inpatient contacts refer to 
number of days. 
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